Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    August 2019
  1. SCHAAF HS, Marais BJ
    The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children.
    Am J Respir Crit Care Med. 2019 Aug 6. doi: 10.1164/rccm.201907-1492.
    PubMed     Text format    


  2. ZAR HJ, Workman LJ, Prins M, Bateman LJ, et al
    Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
    Am J Respir Crit Care Med. 2019 Aug 5. doi: 10.1164/rccm.201904-0772.
    PubMed     Text format     Abstract available


    July 2019
  3. PRAZAK J, Iten M, Cameron DR, Save J, et al
    Bacteriophages Improve Outcome in Experimental Staphylococcus Aureus Ventilator Associated Pneumonia.
    Am J Respir Crit Care Med. 2019 Jul 1. doi: 10.1164/rccm.201812-2372.
    PubMed     Text format     Abstract available


    May 2019
  4. GAUTAM S, Sharma L, Dela Cruz CS
    Teaching an Old Intensivist Neutrophil Tricks: Using Alveolar Neutrophilia to Diagnose Ventilator-associated Pneumonia.
    Am J Respir Crit Care Med. 2019;199:1178-1181.
    PubMed     Text format    


  5. SANDERS DB, Nichols DP
    Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2019;199:1181-1182.
    PubMed     Text format    


  6. NIEDERMAN MS, Nair GB, Matt U, Herold S, et al
    Update in Lung Infections and Tuberculosis 2018.
    Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0606.
    PubMed     Text format    


  7. VAN DE GROEP K, Verboom DM, van de Veerdonk FL, Haas PA, et al
    Detection of Invasive Aspergillosis in Critically Ill Patients with Influenza: the Role of Plasma Galactomannan.
    Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0587.
    PubMed     Text format    


  8. RUSSELL JA, Gordon AC, Walley KR
    Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock.
    Am J Respir Crit Care Med. 2019;199:1049-1051.
    PubMed     Text format    


    April 2019
  9. KRANZER K, Kalsdorf B, Heyckendorf J, Andres S, et al
    New WHO Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?
    Am J Respir Crit Care Med. 2019 Apr 26. doi: 10.1164/rccm.201902-0260.
    PubMed     Text format    


  10. GUPTA E, Jacobs MD, George G, Roman J, et al
    Beyond the ICU: Frailty and Post-ICU Disability. Healthcare Use after Acute Respiratory Distress Syndrome and Severe Sepsis.
    Am J Respir Crit Care Med. 2019;199:1028-1030.
    PubMed     Text format    


    January 2019
  11. DHEDA K, Lenders L, Srivastava S, Magombedze G, et al
    Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.
    Am J Respir Crit Care Med. 2019 Jan 29. doi: 10.1164/rccm.201807-1361.
    PubMed     Text format     Abstract available


  12. TE BRAKE LHM, Boeree MJ, Aarnoutse RE
    Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201811-2101.
    PubMed     Text format    


  13. VELASQUEZ GE, Brooks MB, Coit JM, Sanchez Garavito E, et al
    Reply to: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201812-2281.
    PubMed     Text format    


  14. HANSEN C, Scupp T, Nelson J, Brainard J, et al
    Implications of Procalcitonin Testing in Critically Ill Patients with Sepsis.
    Am J Respir Crit Care Med. 2019;199:232-234.
    PubMed     Text format    


    December 2018
  15. SCICLUNA BP, Baillie JK
    The Search for Efficacious New Therapies in Sepsis Needs to Embrace Heterogeneity.
    Am J Respir Crit Care Med. 2018 Dec 12. doi: 10.1164/rccm.201811-2148.
    PubMed     Text format    


    November 2018
  16. CONSONNI F, Nacoti M, Amini M, Vedovati S, et al
    Severe Necrotizing Staphylococcal Pneumonia with Late Life-Threatening Tracheo-Bronchial Involvement in Infant.
    Am J Respir Crit Care Med. 2018 Nov 15. doi: 10.1164/rccm.201803-0507.
    PubMed     Text format    


  17. JONES TK, Wong HR, Meyer NJ
    HDL Cholesterol: A "Pathogen Lipid Sink" for Sepsis?
    Am J Respir Crit Care Med. 2018 Nov 14. doi: 10.1164/rccm.201811-2084.
    PubMed     Text format    


    October 2018
  18. SCHLUGER NW
    Tuberculosis Elimination, Research, and Respect for Persons.
    Am J Respir Crit Care Med. 2018 Oct 19. doi: 10.1164/rccm.201809-1623.
    PubMed     Text format    


  19. KESHAVJEE S, Amanullah F, Cattamanchi A, Chaisson R, et al
    Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
    Am J Respir Crit Care Med. 2018 Oct 18. doi: 10.1164/rccm.201806-1053.
    PubMed     Text format     Abstract available


  20. MARTINEZ L, Andrews JR
    Improving Tuberculosis Case Finding in Persons Living with Advanced HIV through New Diagnostic Algorithms.
    Am J Respir Crit Care Med. 2018 Oct 1. doi: 10.1164/rccm.201809-1702.
    PubMed     Text format    


    September 2018
  21. YOON C, Semitala FC, Asege L, Katende J, et al
    Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Am J Respir Crit Care Med. 2018 Sep 7. doi: 10.1164/rccm.201803-0490.
    PubMed     Text format     Abstract available


    August 2018
  22. ELKINGTON PT, Bateman AC, Thomas GJ, Ottensmeier CH, et al
    Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.
    Am J Respir Crit Care Med. 2018 Aug 24. doi: 10.1164/rccm.201807-1250.
    PubMed     Text format    


    June 2018
  23. VELASQUEZ GE, Brooks MB, Coit JM, Pertinez H, et al
    Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis: A Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2018 Jun 29. doi: 10.1164/rccm.201712-2524.
    PubMed     Text format     Abstract available


  24. DHEDA K, Lenders L, Magombedze G, Srivastava S, et al
    Drug Penetration Gradients Associated with Acquired Drug Resistance in Tuberculosis Patients.
    Am J Respir Crit Care Med. 2018 Jun 7. doi: 10.1164/rccm.201711-2333.
    PubMed     Text format     Abstract available


    May 2018
  25. LAN F, Zhang N, Holtappels G, Ruyck N, et al
    Staphylococcus aureus Induces Mucosal Type 2 Immune Response via Epithelial Cell Derived Cytokines.
    Am J Respir Crit Care Med. 2018 May 16. doi: 10.1164/rccm.201710-2112.
    PubMed     Text format     Abstract available


    April 2018
  26. MONEDERO-RECUERO I
    Drug-resistant Tuberculosis in Europe. What are We Waiting for?
    Am J Respir Crit Care Med. 2018 Apr 18. doi: 10.1164/rccm.201803-0497.
    PubMed     Text format    


  27. SULIMAN S, Thompson E, Sutherland J, Weiner Rd J, et al
    Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis.
    Am J Respir Crit Care Med. 2018 Apr 6. doi: 10.1164/rccm.201711-2340.
    PubMed     Text format     Abstract available


    March 2018
  28. ABUBAKAR I, Gupta RK, Rangaka MX, Lipman M, et al
    Update in Tuberculosis and Non-tuberculous Mycobacteria 2017.
    Am J Respir Crit Care Med. 2018 Mar 14. doi: 10.1164/rccm.201801-0106.
    PubMed     Text format    


  29. COX D, Keane J
    Platelets and Tuberculosis: Small Cells, Not So Innocent Bystanders.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201802-0279.
    PubMed     Text format    


  30. GUNTHER G, van Leth F, Alexandru S, Altet N, et al
    Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201710-2141.
    PubMed     Text format     Abstract available


    February 2018
  31. SCHWANDER S, Keane J
    Cause or Effect - the Elusive Role of Regulatory T Cells in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 28. doi: 10.1164/rccm.201802-0233.
    PubMed     Text format    


  32. FOX KA, Kirwan DE, Whittington AM, Krishnan N, et al
    Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 8. doi: 10.1164/rccm.201710-2102.
    PubMed     Text format     Abstract available


    December 2017
  33. ERNST JD
    Float Like Bacilli, STING Like a B: Type I Interferons in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Dec 20. doi: 10.1164/rccm.201712-2368.
    PubMed     Text format    



  34. What Is Sepsis?
    Am J Respir Crit Care Med. 2017;196:P21-P22.
    PubMed     Text format    


    November 2017
  35. BENARD A, Sakwa I, Schierloh P, Colom A, et al
    B Cells Producing Type I Interferon Modulate Macrophage Polarization in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Nov 21. doi: 10.1164/rccm.201707-1475.
    PubMed     Text format     Abstract available


    October 2017
  36. DIVANGAHI M, Behr MA
    Cracking the Vaccine Code in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Oct 18. doi: 10.1164/rccm.201707-1489.
    PubMed     Text format     Abstract available


  37. MARTINEZ L, Handel A, Shen Y, Chakraburty S, et al
    A Prospective Validation of a Clinical Algorithm to Detect Tuberculosis in Child Contacts.
    Am J Respir Crit Care Med. 2017 Oct 16. doi: 10.1164/rccm.201706-1210.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: